MAIA 8-K: SEC filing
MAIA Biotechnology
Filed with the SEC on · accession 0001493152-26-052720
MAIA filed a 8-K (current report) with the SEC on Nov 17, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Summary of the filing
MAIA Biotechnology issued a press release reporting consistent strong efficacy results from its expanded Phase 2 THIO-101 study in non-small cell lung cancer.
Key details
✦ Ask GOAX AI about this filing — what it means for MAIA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for MAIA?
Click hereFrequently asked questions
What did MAIA file with the SEC on Nov 17, 2026?
MAIA filed a 8-K (SEC filing). MAIA Biotechnology issued a press release reporting consistent strong efficacy results from its expanded Phase 2 THIO-101 study in non-small cell lung cancer.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other MAIA SEC filings
- 10-Q · SEC filingNov 9, 2026
- 424B3 · Secondary offeringOct 7, 2026
- 8-K · SEC filingOct 6, 2026
- EFFECT · Shelf registrationOct 6, 2026
- 424B3 · Secondary offeringOct 2, 2026
- S-3 · Shelf registrationSep 25, 2026
- EFFECT · SEC filingAug 28, 2026
- S-3 · Shelf registrationAug 21, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 10-Q · SEC filingAug 10, 2026
Get alerts when MAIA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days